Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: cytoreductive surgery and intraperitoneal chemotherapy;Nouveautés thérapeutiques dans la prise en charge des carcinoses péritonéales d'origine digestive : chirurgie de cytoréduction et chimiothérapie intrapéritonéale

Revue de Medecine Interne

Volumn 27, Issue 5, 2006, Pages 382-391

  Glehen, O ^a,b   Cotte, E ^a,b   Brigand, C ^c   Arvieux, C ^d   Sayag Beaujard, A C ^a   Gilly, F N ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cytoreductive surgery; Hyperthermia; Intraperitoneal chemotherapy; Peritoneal carcinomatosis; Peritonectomy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; MITOMYCIN C; OXALIPLATIN;

ACCURACY; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CARCINOMA; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM; HISTOPATHOLOGY; HUMAN; HYPERTHERMIA; MEDICAL ASSESSMENT; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SHORT SURVEY; STOMACH CANCER; SURGICAL TECHNIQUE; TOXICITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; INJECTIONS, INTRAPERITONEAL; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33646092777     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.08.017     Document Type: Short Survey

References (59)

1. Chu D.Z., Lang N.P., Thompson C., Osteen P.K., and Westbrook K.C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63 (1989) 364-367
2. Sadeghi B., Arvieux C., Glehen O., Beaujard A.C., Rivoire M., Baulieux J., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 358-363
3. Jayne D.G., Fook S., Loi C., and Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br. J. Surg. 89 (2002) 1545-1550
4. Begossi G., Gonzalez-Moreno S., Ortega-Perez G., Fon L.J., and Sugarbaker P.H. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma. Eur. J. Surg. Oncol. 28 (2002) 80-87
5. Sugarbaker P.H., and Jablonski K.A. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann. Surg. 221 (1995) 124-132
6. Elias D., Blot F., El Otmany A., Antoun S., Lasser P., Boige V., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
7. Glehen O., Kwiatkowski F., Sugarbaker P.H., Elias D., Levine E.A., De Simone M., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J. Clin. Oncol. 22 (2004) 3284-3292
8. Yonemura Y., Fujimura T., Nishimura G., Falla R., Sawa T., Katayama K., et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119 (1996) 437-444
9. Glehen O., Schreiber V., Cotte E., Sayag-Beaujard A.C., Osinski D., Freyer G., et al. Treatment of peritoneal carcinomatosis arising from gastric cancer by cytoreductive surgery and intraperitoneal chemohyperthermia. Arch. Surg. 139 (2004) 20-26
10. Verwaal V.J., Van Ruth S., De Bree E., Van Sloothen G.W., Van Tinteren H., Boot H., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy vs systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J. Clin. Oncol. 21 (2003) 3737-3743
11. Sugarbaker P.H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin. Surg. Oncol. 14 (1998) 254-261
12. Midgley R., and Kerr D. Colorectal cancer. Lancet 353 (1999) 391-399
13. Isacoff W.H., and Borud K. Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overview. World J. Surg. 21 (1997) 748-762
14. Zang R.Y., Zhang Z.Y., Li Z.T., Chen J., Tang M.Q., Liu Q., et al. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J. Surg. Oncol. 75 (2000) 24-30
15. Gilly F.N., Carry P.Y., Sayag A.C., Brachet A., Panteix G., Salle B., et al. Regional chemotherapy (with mitomycin C) and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41 (1994) 124-129
16. Sugarbaker P.H. Peritonectomy procedures. Ann. Surg. 221 (1995) 29-42
17. Glehen O., Osinski D., Cotte E., Kwiatkowski F., Freyer G., Isaac S., et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann. Surg. Oncol. 10 (2003) 863-869
18. Stephens A.D., Alderman R., Chang D., Edwards G.D., Esquivel J., Sebbag G., et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann. Surg. Oncol. 6 (1999) 790-796
19. Glehen O., Mohamed F., and Gilly F.N. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 5 (2004) 219-228
20. Glehen O., Beaujard A.C., Arvieux C., Huber O., and Gilly F.N. Les carcinoses péritonéales. Traitement chirurgical, péritonectomies et chimiohyperthermie intrapéritonéale. Gastroenterol. Clin. Biol. 26 (2002) 210-215
21. Elias D.M., and Ouellet J.F. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results. Surg. Oncol. Clin. N. Am. 10 (2001) 915-933 [xi]
22. Sugarbaker P.H., Mora J.T., Carmignani P., Stuart O.A., and Yoo D. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 10 (2005) 112-122
23. Elias D., Antoun S., Goharin A., Otmany A.E., Puizillout J.M., and Lasser P. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int. J. Surg. Investig. 1 (2000) 431-439
24. Elias D., Matsuhisa T., Sideris L., Liberale G., Drouard-Troalen L., Raynard B., et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann. Oncol. 15 (2004) 1558-1565
25. Yonemura Y., de Aretxabala X., Fujimura T., Fushida S., Katayama K., Bandou E., et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 48 (2001) 1776-1782
26. Hamazoe R., Maeta M., and Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 73 (1994) 2048-2052
27. Fujimoto S., Takahashi M., Mutou T., Kobayashi K., and Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 85 (1999) 529-534
28. Huang Y., Hagiwara A., Wang W., Su G., Qi X., Ma D., et al. Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer. Anticancer Drugs 13 (2002) 431-435
29. Glehen O., Mithieux F., Osinsky D., Beaujard A.C., Freyer G., Guertsch P., et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J. Clin. Oncol. 21 (2003) 799-806
30. Witkamp A.J., de Bree E., Kaag M.M., Boot H., Beijnen J.H., van Slooten G.W., et al. Extensive cytoreductive surgery followed by intraoperative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur. J. Cancer 37 (2001) 979-984
31. Cancer JRSfG. The general rules for the gastric cancer study in surgery and pathology. I. Clinical classification. Jpn. J. Surg. 11 (1981) 127-139
32. Beaujard A.C., Glehen O., Caillot J.L., Francois Y., Bienvenu J., Panteix G., et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88 (2000) 2512-2519
33. Pestieau S.R., and Sugarbaker P.H. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis. Colon Rectum 43 (2000) 1341-1346 (discussion 1347-8)
34. Mansvelt B., Bertrand C., Nockerman P., Arnould P., Delvaux P., Lechien X., et al. Étude de toxicité et résultats de la chimiohyperthermie intrapéritonéale chez 28 patients en carcinose péritonéale. Ann. Chir. 51 (1997) 60-67
35. McQuellon R.P., Loggie B.W., Fleming R.A., Russell G.B., Lehman A.B., and Rambo T.D. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur. J. Surg. Oncol. 27 (2001) 65-73
36. Sayag-Beaujard A.C., Francois Y., Glehen O., Sadeghi-Looyeh B., Bienvenu J., Panteix G., et al. Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res. 19 (1999) 1375-1382
37. McQuellon R.P., Loggie B.W., Lehman A.B., Russell G.B., Fleming R.A., Shen P., et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann. Surg. Oncol. 10 (2003) 155-162
38. Slim K., Glehen O., and Gilly F.N. Carcinoses péritonéales primitives et d'origine digestive traitées par chimiohyperthermie intrapéritonéale. Ann. Chir. 128 (2003) 580-589
39. Jacquet P., Stephens A.D., Averbach A.M., Chang D., Ettinghausen S.E., Dalton R.R., et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 77 (1996) 2622-2629
40. Verwaal V.J., Tinteren Hv H., Ruth S.V., and Zoetmulder F.A. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J. Surg. Oncol. 85 (2004) 61-67
41. Witkamp A.J., de Bree E., Kaag M.M., van Slooten G.W., van Coevorden F., and Zoetmulder F.A. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br. J. Surg. 88 (2001) 458-463
42. Shen P., Levine E.A., Hall J., Case D., Russell G., Fleming R., et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch. Surg. 138 (2003) 26-33
43. Rey Y., Porcheron J., Talabard J.N., Szafnicki K., and Balique J.G. Carcinoses péritonéales traitées par chirurgie de cytoréduction et chimiohyperthermie intrapéritonéale. Ann. Chir. 125 (2000) 631-642
44. Pilati P., Mocellin S., Rossi C.R., Foletto M., Campana L., Nitti D., et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann. Surg. Oncol. 10 (2003) 508-513
45. Shen P., Hawksworth J., Lovato J., Loggie B.W., Geisinger K.R., Fleming R.A., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann. Surg. Oncol. 11 (2004) 178-186
46. Verwaal V.J., van Tinteren H., van Ruth S., and Zoetmulder F.A. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br. J. Surg. 91 (2004) 739-746
47. Glehen O., Cotte E., Schreiber V., Sayag-Beaujard A.C., Vignal J., and Gilly F.N. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br. J. Surg. 91 (2004) 747-754
48. Elias D., Bonnay M., Puizillou J.M., Antoun S., Demirdjian S., El O.A., et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann. Oncol. 13 (2002) 267-272
49. Hirose K., Katayama K., Iida A., Yamaguchi A., Nakagawara G., Umeda S., et al. Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology 57 (1999) 106-114
50. Fujimoto S., Takahashi M., Mutou T., Kobayashi K., Toyosawa T., Isawa E., et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79 (1997) 884-891
51. Brigand C., Monneuse O., Mohamed F., Sayag A., Gilly F.N., and Glehen O. Malignant peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal chemohyperthermia: results of a prospective study. Ann. Surg. Oncol. (2005) (In Press)
52. Sugarbaker P.H., Acherman Y.I., Gonzalez-Moreno S., Ortega-Perez G., Stuart O.A., Marchettini P., et al. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin. Oncol. 29 (2002) 51-61
53. Loungnarath R., Causeret S., Bossard N., Sayag A., Brigand C., Gilly F.N., et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for the treatment of pseudomyxoma peritonei: a prospective study. Dis. Colon Rectum 48 (2005) 1372-1379
54. Ma G.Y., Bartlett D.L., Reed E., Figg W.D., Lush R.M., Lee K.B., et al. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma. Cancer J. Sci. Am. 3 (1997) 174-179
55. Feldman A.L., Libutti S.K., Pingpank J.F., Bartlett D.L., Beresnev T.H., Mavroukakis S.M., et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J. Clin. Oncol. 21 (2003) 4560-4567
56. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann. Surg. Oncol. 6 (1999) 727-731
57. Deraco M., Casali P., Inglese M.G., Baratti D., Pennacchioli E., Bertulli R., et al. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. J. Surg. Oncol. 83 (2003) 147-153
58. Nitecki S.S., Wolff B.G., Schlinkert R., and Sarr M.G. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann. Surg. 219 (1994) 51-57
59. Gough D.B., Donohue J.H., Schutt A.J., Gonchoroff N., Goellner J.R., Wilson T.O., et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann. Surg. 219 (1994) 112-119